Wed, Sep 17, 2014, 10:47 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

PROLOR Biotech, Inc. Message Board

  • birdshooter_6 birdshooter_6 Apr 11, 2011 12:06 PM Flag


    Would like your opinion.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Bird,

      As I understand it, PROLOR was conducting the Phase II in various groups--some having injections at low and middle doses 1x per week and others having higher doses at 1x per every two weeks.

      Today's announcement ONLY gave an insight in to the low dose and middle dose (i.e. the 1x every week groups) and those worked (i.e. efficacy is achievable and IGF-1 was in range). It didn't mention the higher doses (i.e. 1x every two weeks) because these probably aren't done yet.

      Consequently, WORST case scenario hGH-CTP will work 1x per week vs daily injections. We have NOT seen if the IGF-1 is in range with the higher doses/1x every two weeks. Therefore, top line results may show that hGH-CTP can be injected 1x every two weeks (upside) or it may show that we stay at the WORST case scenario which is 1x every week. This WORST case is still 6 injections less than what's currently in the market.


Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.